Literature DB >> 18415221

[Pain treatment in cancer patients.].

R Twycross1.   

Abstract

Freedom from cancer pain is one of the four priorities of the WHO Cancer Control Programme. Every day 3.5 million people are suffering from cancer pain, and most do not receive adequate relief. A lack of training in cancer pain management at most nursing and medical schools is the principal reason for this, coupled with limited availability of oral strong opioids in many countries. Education is the key to progress in cancer pain management. Health workers must appreciate that: 1. Attention must be paid to all aspects of suffering -physical, psychological, social and spiritual. 2. In advanced cancer, most patients with pain have multiple pain. 3. Pain experienced in carcinoma is not always caused by the tumour. 4. There is more to pain management than the use of analgesics. 5. In the case of opioid-responsive pains, analgesics should be administered by mouth according to a regular time-schedule and with dose increments. 6. Adjuvant medication is generally necessary. 7. Opioid-resistant pains require other forms of treatment. 8. Pain is the physiological antagonist to the central depressant effects of opioids. 9. Opioid tolerance is not a problem in practice. 10. Psychological dependence does not occur in patients receiving opioids for pain relief. 11. Patients receiving analgesics must be carefully monitored. 12. Teamwork is necessary for good results.

Entities:  

Year:  1990        PMID: 18415221     DOI: 10.1007/BF02527837

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  15 in total

1.  A piece of my mind: painful prescriptions.

Authors:  C Stratton Hill
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

2.  The use of quantitative methods in planning national cancer control programmes. A WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

3.  A validation study of the WHO method for cancer pain relief.

Authors:  V Ventafridda; M Tamburini; A Caraceni; F De Conno; F Naldi
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

4.  Wisconsin initiative for improving cancer pain management: progress report.

Authors:  D E Joranson; J L Dahl; D Engber
Journal:  J Pain Symptom Manage       Date:  1987       Impact factor: 3.612

5.  Patterns of narcotic drug use in a cancer pain clinic.

Authors:  R M Kanner; K M Foley
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

6.  [Palliative care and treatment of cancer pain in geriatrics. Our institutional experience].

Authors:  O Rappaz; J Tripiana; C H Rapin; J Stjernswärd; J P Junod
Journal:  Ther Umsch       Date:  1985-12

7.  Addiction rare in patients treated with narcotics.

Authors:  J Porter; H Jick
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

8.  Prostaglandins, aspirin-like drugs and analgesia.

Authors:  S H Ferreira
Journal:  Nat New Biol       Date:  1972-12-13

Review 9.  The treatment of cancer pain.

Authors:  K M Foley
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

10.  Pain in far-advanced cancer.

Authors:  Robert G Twycross; Sarah Fairfield
Journal:  Pain       Date:  1982-11       Impact factor: 6.961

View more
  12 in total

1.  [Not Available].

Authors:  B Kossmann; U Thoden
Journal:  Schmerz       Date:  1991-06       Impact factor: 1.107

2.  [WHO step II-clinical reality or a didactic instrument?].

Authors:  R Freynhagen; M Zenz; M Strumpf
Journal:  Schmerz       Date:  1994-12       Impact factor: 1.107

3.  [Oral papaverine prevents morphine-induced constipation without interfering with analgesia achieved with oral morphine].

Authors:  I Jurna; K Jurna; J Baldauf; M Zenz
Journal:  Schmerz       Date:  1996-02-15       Impact factor: 1.107

Review 4.  Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states.

Authors:  H A Friedel; A Fitton
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

5.  [Not Available].

Authors:  M Zenz
Journal:  Schmerz       Date:  1991-03       Impact factor: 1.107

6.  [Pain therapy in cancer pain patients: control of therapy with the Potsdam pain questionnaire.].

Authors:  K Gastmeier
Journal:  Schmerz       Date:  1991-09       Impact factor: 1.107

7.  [New modes of opioid administration.].

Authors:  H W Striebel; R Schwagmeier; N Boerger
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

8.  [Cancer pain: Coping and communication.].

Authors:  H Seemann
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

9.  [Continuous administration of opiates with implantable drug delivery systems in patients with intractable non-malignant pain.].

Authors:  M Winkelmüller; W Winkelmüller
Journal:  Schmerz       Date:  1991-03       Impact factor: 1.107

10.  [Oral administration of slow-release naloxone for prevention of constipation but not analgesia following oral morphine.].

Authors:  I Jurna; J Baldauf
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.